Procter & Gamble Targets Range Slashed to $146–$179; Beauty Up 4%, Baby Care Down
Analysts adjusted Procter & Gamble's price targets to a $146–$179 range, and Massachusetts Financial cut its stake by 1.5%, sparking a 1% share decline. Beauty unit sales rose 4% on premium innovation, while Baby Care volumes fell due to inventory headwinds with a rebound expected in H2.
1. Analyst Price Target Adjustments
Barclays lowered its price target to $146, Bank of America cut to $167, and Wells Fargo reduced to $158 while Jefferies raised its target to $179, reflecting divergent views on the stock's upside potential.
2. Valuation Metrics
Procter & Gamble's forward P/E ratio stands at 20.30X compared with the industry average of 17.76X, contributing to a Value Score of D and raising questions about its premium valuation.
3. Segment Performance
The Beauty segment delivered 4% sales growth driven by premium product innovation, whereas Baby Care volumes declined amid inventory build-up, with management forecasting improvements in the second half.
4. Investor Reactions and Market Impact
Massachusetts Financial trimmed its Procter & Gamble holding by 1.5%, and the share price dipped 1% on lower trading volume, signaling caution among institutional investors.